Power Doppler ultrasound and contrast-enhanced ultrasound demonstrate non-invasive tumour vascular response to anti-vascular therapy in canine cancer patients

Combretastatin A4-phosphate (CA4P) is an anti-vascular agent which selectively shuts down blood supply in tumours, resulting in extensive tumour necrosis. The aim of this study was to assess in vivo, non-invasive ultrasound techniques for the early evaluation of tumour perfusion following CA4P treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Abma, Eline, Stock, Emmelie, De Spiegelaere, Ward, Van Brantegem, Leen, Vanderperren, Katrien, Ni, Yicheng, Vynck, Matthijs, Daminet, Sylvie, De Clercq, Kaat, de Rooster, Hilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592898/
https://www.ncbi.nlm.nih.gov/pubmed/31239493
http://dx.doi.org/10.1038/s41598-019-45682-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592898/
https://www.ncbi.nlm.nih.gov/pubmed/31239493
http://dx.doi.org/10.1038/s41598-019-45682-2

Ejemplares similares